Department of Biomedical Engineering, W.J. Kolff Institute for Biomedical Engineering and Materials Science, University Medical Center Groningen, University of Groningen, Ant. Deusinglaan 1, 9713 AV Groningen, The Netherlands.
Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, FI-00014 Helsinki, Finland.
ACS Appl Bio Mater. 2023 Oct 16;6(10):4269-4276. doi: 10.1021/acsabm.3c00475. Epub 2023 Sep 29.
Exosomes are natural endogenous extracellular vesicles with phospholipid-based bilayer membrane structures. Due to their unique protein-decorated membrane properties, exosomes have been regarded as promising drug carriers to deliver small molecules and genes. A number of approaches have been developed for exosome-based drug loading. However, the drug loading capability of exosomes is inconsistent, and the effects of loading methods on the therapeutic efficacy have not been investigated in detail. Herein, we developed anti-inflammatory drug-loaded exosomes as an immunomodulatory nanoplatform. Naïve macrophage-derived exosomes (Mϕ-EVs) were loaded with the anti-inflammatory drug mycophenolic acid (MPA) by three major loading methods. Loading into exosomes significantly enhanced anti-inflammatory and antioxidation effects of MPA in vitro compared to free drugs. These findings provide a scientific basis for developing naïve macrophage-secreted exosomes as drug carriers for immunotherapy.
外泌体是具有磷脂双层膜结构的天然内源性细胞外囊泡。由于其独特的蛋白修饰膜特性,外泌体被认为是有前途的药物载体,可用于递送小分子和基因。已经开发了许多基于外泌体的药物加载方法。然而,外泌体的药物加载能力不一致,并且加载方法对治疗效果的影响尚未详细研究。在此,我们开发了载有抗炎药的外泌体作为一种免疫调节纳米平台。通过三种主要的加载方法,将抗炎药霉酚酸(MPA)加载到幼稚巨噬细胞衍生的外泌体(Mϕ-EVs)中。与游离药物相比,将 MPA 载入外泌体可显著增强其体外抗炎和抗氧化作用。这些发现为开发幼稚巨噬细胞分泌的外泌体作为免疫治疗的药物载体提供了科学依据。